BOSTON, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Gunderson Dettmer advised Aldeyra Therapeutics, Inc. on a follow-on public offering of 5,250,000 shares of its common stock at $13.75 per share for a total of approximately $72 million in aggregate gross proceeds. Corporate partner Jay Hachigian, of counsel Keith Scherer, and associates Albert Vanderlaan, Naomi Smith and John Maciejewski led the team advising Aldeyra.
Aldeyra anticipates using the net proceeds from the offering for the continued development of its lead compound reproxalap and other product candidates, as well as for debt maintenance, working capital and other general corporate purposes.
Citigroup acted as lead bookrunning manager for the offering. Cantor Fitzgerald & Co. acted as a bookrunning manager. Laidlaw & Company (UK) Ltd., Janney Montgomery Scott and JonesTrading acted as co-managers.
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics is developing next-generation medicines to improve the lives of patients with immune-mediated diseases. Its lead product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and other forms of ocular inflammation. The company is also developing other product candidates for autoimmune disease, post-transplant lymphoproliferative disease, retinal inflammation, metabolic disease and cancer. None of Aldeyra's product candidates have been approved for sale in the U.S. or elsewhere.
About Gunderson Dettmer
Gunderson Dettmer is the only business law firm of its kind—singularly focused on the global venture capital and emerging technology marketplace. With 220 attorneys in nine offices—Silicon Valley, Boston, Los Angeles, New York, San Diego, Ann Arbor, San Francisco, Singapore and Beijing, China—it represents more than 2,000 high-growth companies from a broad range of industries in every stage of development. The firm provides its clients with counsel on general corporate and securities law, mergers and acquisitions, financings, intellectual property and commercial agreements, strategic alliances, executive compensation and tax matters.
Monica Rodriguez Kuniyoshi
Chief Marketing Officer
Phone: 650-463-5337
Email: mkuniyoshi@gunder.com